national strategic plan
When countries received their allocation letters on 15 December 2016, a lot of critical information was shared about the next funding cycle (2017-2019).
Ahead of the Global Fund's replenishment push in December, countries are being strongly encouraged to boost domestic funding for the fight against AIDS, TB and malaria to bridge the gap in unmet needs.
A conference in the Ethiopian capital Addis Ababa on 11-12 November brought together ministers of health and finance, civil society groups and donors to discuss how to accelerate domestic spending on health in Africa.
The Global Fund has developed new minimum standards for implementers. Entities covered by the standards include principal recipients (PRs), large sub-recipients (SRs) and other associated actors, such as public- or private-sector entities involved in the pharmaceutical and health products procurement and supply chain, as well as components of the national health system.
African governments have not lived up to their commitment in the Abuja Declaration to allocate 15% of their annual budgets to health expenditure.
Wave 2 of the National Strategy Application (NSA) funding channel will probably involve joint assessments of national disease strategies rather than just assessment by the Global Fund, but the form that these assessments will take is not yet decided.
On 28-30 April 2010, the Global Fund Board held its 21st board meeting in Geneva. GFO was present, with observer status.
The Global Fund Board has approved two of the nine Round 9 proposals whose original rejection had been appealed by the applicants. The newly approved proposals are an HIV proposal from Pakistan that will cost $11.9 million and a TB proposal from Ukraine that will cost $34.6 million (costs are for the first two years). The approvals are subject to a number of requests for clarification being successfully responded to in a timely manner.
Key decisions made by the Global Fund Board at the meeting that ended on Friday were as follows.